Advanced Care Planning in Oncology

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Palliative and Supportive Care".

Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 3464

Special Issue Editor


E-Mail Website
Guest Editor
Population Cancer Research, Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS B3H 2Y9, Canada
Interests: health services research and knowledge translation/implementation science, related to cancer

Special Issue Information

Advance care planning (ACP) is the process by which a patient reflects on their goals, values, and beliefs to make decisions about their future medical care. In older adult populations, ACP has been associated with improved outcomes, including reductions in aggressive care near the end of life, increased use of hospice care, and improved bereavement outcomes among family members. As a result, existing oncology guidelines recommend that ACP occur with patients who have a life expectancy of months to years. However, these conversations are uncommon in oncology settings, with rates of ACP documentation as low as 10% in outpatient oncology. This Special Issue of Current Oncology aims to showcase research that investigates issues related to advance care planning with cancer patients. We invite researchers to address either one of the following topics or a related topic:

  • Provider-, patient-, and system-level interventions to implement ACP in oncology practice;
  • Team-based approaches to ACP in oncology practice, including roles and outcomes of physician- vs other health professional-led discussions;
  • Patient and family preferences for and experiences with ACP, including those of underserved and diverse populations;
  • Impacts of ACP on patient, family, provider, and/or health system outcomes;
  • Initiating and conducting ACP with cancer patients during a global pandemic.
Dr. Robin Urquhart
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • advance care planning
  • advance directives
  • cancer
  • implementation science
  • communication

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

10 pages, 822 KiB  
Commentary
The Serious Illness Care Program in Oncology: Evidence, Real-World Implementation and Ongoing Barriers
by Safiya Karim, Oren Levine and Jessica Simon
Curr. Oncol. 2022, 29(3), 1527-1536; https://doi.org/10.3390/curroncol29030128 - 02 Mar 2022
Cited by 8 | Viewed by 2947
Abstract
The Serious Illness Care Program (SICP), designed by Ariadne Labs, is a multicomponent intervention to improve conversations about values and goals for patients with a life-limiting illness. In oncology, implementation of the SICP achieved more, earlier, and better-quality conversations and reduced anxiety and [...] Read more.
The Serious Illness Care Program (SICP), designed by Ariadne Labs, is a multicomponent intervention to improve conversations about values and goals for patients with a life-limiting illness. In oncology, implementation of the SICP achieved more, earlier, and better-quality conversations and reduced anxiety and depression among patients with advanced cancer. In this commentary, we describe the SICP, including results from the cluster-randomized trial, provide examples of real-world implementation of this program, and highlight ongoing challenges and barriers that are preventing widespread adoption of this intervention into routine practice. For the SICP to be successfully embedded into routine patient care, it will require significant effort, including ongoing leadership support and training opportunities, champions from all sectors of the interdisciplinary team, and adaptation of the program to a wider range of patients. Future research should also investigate how early conversations can be translated into personalized care plans for patients. Full article
(This article belongs to the Special Issue Advanced Care Planning in Oncology)
Show Figures

Figure 1

Back to TopTop